Klingenstein Fields & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.4M | Sell |
71,998
-768
| -1% | -$417K | 1.39% | 24 |
|
|
2025
Q4 | $42.2M | Sell |
72,766
-401
| -0.5% | -$227K | 1.58% | 21 |
|
|
2025
Q3 | $35.5M | Sell |
73,167
-166
| -0.2% | -$77.3K | 1.34% | 24 |
|
|
2025
Q2 | $29.7M | Sell |
73,333
-2,154
| -3% | -$901K | 1.18% | 29 |
|
|
2025
Q1 | $37.6M | Sell |
75,487
-433
| -0.6% | -$235K | 1.6% | 20 |
|
|
2024
Q4 | $39.5M | Sell |
75,920
-395
| -0.5% | -$217K | 1.59% | 18 |
|
|
2024
Q3 | $47.2M | Buy |
76,315
+135
| +0.2% | +$79.9K | 1.88% | 14 |
|
|
2024
Q2 | $42.1M | Sell |
76,180
-2,094
| -3% | -$1.2M | 1.75% | 16 |
|
|
2024
Q1 | $45.5M | Sell |
78,274
-1,828
| -2% | -$1.03M | 1.89% | 12 |
|
|
2023
Q4 | $42.5M | Sell |
80,102
-2,046
| -2% | -$990K | 1.9% | 12 |
|
|
2023
Q3 | $41.6M | Sell |
82,148
-107
| -0.1% | -$57K | 2.03% | 14 |
|
|
2023
Q2 | $42.9M | Sell |
82,255
-771
| -0.9% | -$416K | 1.98% | 13 |
|
|
2023
Q1 | $47.9M | Sell |
83,026
-1,073
| -1% | -$605K | 2.4% | 10 |
|
|
2022
Q4 | $46.3M | Sell |
84,099
-1,880
| -2% | -$996K | 2.4% | 9 |
|
|
2022
Q3 | $43.6M | Sell |
85,979
-919
| -1% | -$514K | 2.4% | 11 |
|
|
2022
Q2 | $47.2M | Buy |
86,898
+583
| +0.7% | +$321K | 2.46% | 10 |
|
|
2022
Q1 | $51M | Sell |
86,315
-180
| -0.2% | -$103K | 2.18% | 11 |
|
|
2021
Q4 | $57.7M | Sell |
86,495
-1,293
| -1% | -$807K | 2.32% | 12 |
|
|
2021
Q3 | $50.2M | Sell |
87,788
-954
| -1% | -$524K | 2.14% | 12 |
|
|
2021
Q2 | $44.8M | Sell |
88,742
-3
| -0% | -$1.42K | 1.85% | 14 |
|
|
2021
Q1 | $40.5M | Sell |
88,745
-3,064
| -3% | -$1.46M | 1.83% | 16 |
|
|
2020
Q4 | $42.8M | Sell |
91,809
-1,629
| -2% | -$764K | 1.94% | 14 |
|
|
2020
Q3 | $41.3M | Sell |
93,438
-2,486
| -3% | -$1.03M | 2.06% | 10 |
|
|
2020
Q2 | $34.8M | Sell |
95,924
-98
| -0.1% | -$32.8K | 1.9% | 12 |
|
|
2020
Q1 | $27.2M | Sell |
96,022
-121
| -0.1% | -$38.2K | 1.77% | 14 |
|
|
2019
Q4 | $31.2M | Sell |
96,143
-2,673
| -3% | -$811K | 1.57% | 17 |
|
|
2019
Q3 | $28.8M | Sell |
98,816
-1,947
| -2% | -$558K | 1.52% | 19 |
|
|
2019
Q2 | $29.6M | Sell |
100,763
-734
| -0.7% | -$202K | 1.54% | 16 |
|
|
2019
Q1 | $27.8M | Sell |
101,497
-39,474
| -28% | -$9.82M | 1.49% | 20 |
|
|
2018
Q4 | $31.5M | Sell |
140,971
-2,103
| -1% | -$493K | 1.34% | 19 |
|
|
2018
Q3 | $34.9M | Sell |
143,074
-3,565
| -2% | -$820K | 1.25% | 21 |
|
|
2018
Q2 | $30.4M | Buy |
146,639
+296
| +0.2% | +$62.8K | 1.16% | 30 |
|
|
2018
Q1 | $30.2M | Buy |
146,343
+323
| +0.2% | +$67.8K | 1.16% | 30 |
|
|
2017
Q4 | $27.7M | Sell |
146,020
-995
| -0.7% | -$191K | 1.02% | 35 |
|
|
2017
Q3 | $27.8M | Sell |
147,015
-18,228
| -11% | -$3.3M | 1.07% | 33 |
|
|
2017
Q2 | $28.8M | Buy |
165,243
+512
| +0.3% | +$86K | 1.13% | 32 |
|
|
2017
Q1 | $25.3M | Buy |
164,731
+139,893
| +563% | +$21.4M | 1.03% | 40 |
|
|
2016
Q4 | $3.5M | Sell |
24,838
-2,650
| -10% | -$391K | 0.15% | 79 |
|
|
2016
Q3 | $4.37M | Sell |
27,488
-13,054
| -32% | -$2.01M | 0.2% | 74 |
|
|
2016
Q2 | $5.99M | Sell |
40,542
-895
| -2% | -$132K | 0.28% | 69 |
|
|
2016
Q1 | $5.87M | Sell |
41,437
-791
| -2% | -$106K | 0.29% | 68 |
|
|
2015
Q4 | $5.99M | Buy |
42,228
+2,480
| +6% | +$331K | 0.3% | 67 |
|
|
2015
Q3 | $4.86M | Buy |
39,748
+18,336
| +86% | +$2.39M | 0.24% | 69 |
|
|
2015
Q2 | $2.78M | Buy |
+21,412
| New | +$2.79M | 0.12% | 88 |
|
Other funds holding TMO
VCM
Klingenstein Fields & Co's TMO Position: Q1 2026 in Review
Klingenstein Fields & Co reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q1 2026, selling an estimated $417K and leaving 71,998 shares worth $35.4M. The position accounts for 1.39% of the portfolio, ranked #24.
Klingenstein Fields & Co first reported a position in TMO in Q2 2015 and has held it in 44 quarters since. The position peaked at $57.7M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Klingenstein Fields & Co held 71,998 shares of Thermo Fisher Scientific worth $35.4M as of Q1 2026.
- Klingenstein Fields & Co sold 768 Thermo Fisher Scientific shares in Q1 2026, an estimated $417K.
- Thermo Fisher Scientific made up 1.39% of Klingenstein Fields & Co's portfolio in Q1 2026, its #24 holding.
- Klingenstein Fields & Co first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 44 quarters since.
- Klingenstein Fields & Co's Thermo Fisher Scientific position peaked at $57.7M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.